Ancillary reagents are used during the manufacturing of cell therapy products, however, are not intended to be part of the final products. The ancillary reagents are used as a growth and survival promoter for certain cell populations and have profound effects on a cell product.

Ancillary reagents for cell based therapies include antibiotics, cytokines, growth factors, culture media, enzymes and serum derivatives. Ancillary reagents might affects the efficacy of cell based products, thus, quality assurance of ancillary reagents are critical for cell based products. The standers for ancillary reagents are developed by The US Pharmacopeia Convention (USP). On the other hand, there are no regulations specific for the ancillary reagents.

There are still many challenges related to ancillary reagents in the development of cell-based therapeutics, such as extensive and expensive qualification activities, manufacturing reagents under GMP. Additional challenge includes, the development of analytical test methods and potency assays for ancillary reagents that are biological in nature to assist with key qualification activities assessing purity, identity, safety and even suitability. Some ancillary reagents are approved pharmaceutical products such as Heparin and insulin, are available as GMP-grade materials and often used in cell product manufacturing.

The growth ancillary reagents market is primarily driven by the growing manufacturing practices of cell based therapies, growing research and development activities for the development of cell and tissue based therapies there by increasing adoption of ancillary reagents.

The global market for bariatric surgical procedures is expected to be driven by increasing incidence of obesity, diabetes and

The global market for bariatric surgical procedures is segmented on basis of surgery type, end user and geography:

Based on end user, the global ancillary reagents market has been segmented into pharmaceutical manufacturers, biotech companies, and research organizations. Pharmaceutical manufacturers are expected to contribute highest share in the global ancillary reagents market over the forecast period due to large scale adoption of ancillary reagents during the manufacturing of cell based therapies.

On the basis of regional presence, global ancillary reagents market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to lead the global market due to presence of large number of pharmaceutical companies and higher adoption of ancillary reagents, while Europe is expected to hold second largest market share in the global market.

Market in Asia-Pacific region is expected to witness significant growth owing to increasing research and development activities for cell based therapies and low cost manufacturing process. In addition, increasing R&D expenditure of pharmaceutical companies and growing trend of contract manufacturing in Asian countries is expected to boost the market growth. 

Some of the players operating in global ancillary reagents market are Becton, Dickinson and Company, Sigma-Aldrich, Beckman Coulter, Genemed Biotechnologies, Inc., Leica Biosystems, Thermo Fisher Scientific Inc., and Genetex Inc. others.

• Ancillary reagents market Segments
• Ancillary reagents market Dynamics
• Historical Actual Market Size, 2012 - 2016
• Ancillary Reagents Market Size & Forecast 2017 to 2025
• Bariatric Surgical Procedures Market Current Trends/Issues/Challenges
• Competition & Companies involved
• Ancillary reagents market Drivers and Restraints

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

• Shifting Industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size Recent industry trends
• Key Competition landscape
• Strategies of key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance